[Risk reduction and drug use in detention: study about the detainees of Liancourt Penitentiary].

Autor: Sannier O; UCSA du Centre Pénitentiaire de Liancourt, Liancourt, France. olivier.sannier@gmail.com, Verfaillie F, Lavielle D
Jazyk: francouzština
Zdroj: Presse medicale (Paris, France : 1983) [Presse Med] 2012 Jul; Vol. 41 (7-8), pp. e375-85. Date of Electronic Publication: 2012 Mar 02.
DOI: 10.1016/j.lpm.2011.12.015
Abstrakt: Background: The prison population is drug users. Recent debates around the provision of devices to reduce the risks associated with drug use (syringe exchange programs and snort kit) lead us to question local practices of the prison population.
Method: An anonymous questionnaire was offered to the prison population of the Liancourt penitentiary. The questions addressed the use of drugs before and during incarceration, knowledge of HIV and B and C hepatitis status, taking an opiate substitution treatment and advice on the implementation of syringe exchange programs and snort kit.
Results: A percentage of 54.4 of the prisoners responded to the questionnaire. An amount of 60.1 % of respondents consumed at least one drug before incarceration and 43.6 % of respondents consumed at least one drug during their incarceration. Cannabis was the most consumed drug before and during incarceration. Barely half of respondents reported knowing their HIV and hepatitis B and C status. Over 10 % of respondents said they were interesting in establishing needle exchange programs or snort kit.
Discussion: The prison concentrate drug users and is not a repressive tool of efficient risk reduction. The strategies implemented by the medical unit of Liancourt prison require adaptations that warrant development of health resources. Then, only new tools to reduce risks associated with drug use can be established.
(Copyright © 2012 Elsevier Masson SAS. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: